Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Invested Capital (2024 - 2025)

Adma Biologics (ADMA) has disclosed Return on Invested Capital for 4 consecutive years, with 0.36% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 39.0% year-over-year to 0.36%, compared with a TTM value of 0.36% through Dec 2025, down 39.0%, and an annual FY2025 reading of 0.4%, down 50.0% over the prior year.
  • Return on Invested Capital was 0.36% for Q4 2025 at Adma Biologics, down from 0.54% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.75% in Q4 2024 and bottomed at 0.3% in Q1 2024.